| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |